Yoo, C., Kang, J., Kim, K., Lee, J., Ryoo, B., Chang, H., . . . Kim, S. C. (2017). Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: Improved efficacy compared with gemcitabine-based regimen. Oncotarget.
Citação norma ChicagoYoo, Changhoon, et al. "Efficacy and Safety of Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: Improved Efficacy Compared With Gemcitabine-based Regimen." Oncotarget 2017.
Citação norma MLAYoo, Changhoon, et al. "Efficacy and Safety of Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: Improved Efficacy Compared With Gemcitabine-based Regimen." Oncotarget 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.